Pivotal Phase 3 Theranostic Trials: Future Indications.

Fendler WP, Hofman MS, Kersting D, Calais J, Hope TA

Open source

DOI
10.2967/jnumed.125.269486
Published
2026 Sep 11
Container
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2967/jnumed.125.269486,
  title = {Pivotal Phase 3 Theranostic Trials: Future Indications.},
  author = {Fendler WP and Hofman MS and Kersting D and Calais J and Hope TA},
  year = {2026},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  doi = {10.2967/jnumed.125.269486},
  url = {https://doi.org/10.2967/jnumed.125.269486}
}

RIS

TY  - JOUR
TI  - Pivotal Phase 3 Theranostic Trials: Future Indications.
AU  - Fendler WP
AU  - Hofman MS
AU  - Kersting D
AU  - Calais J
AU  - Hope TA
PY  - 2026
JO  - Journal of nuclear medicine : official publication, Society of Nuclear Medicine
DO  - 10.2967/jnumed.125.269486
UR  - https://doi.org/10.2967/jnumed.125.269486
ER  - 

APA

WP, F., MS, H., D, K., J, C., & TA, H. (2026). Pivotal Phase 3 Theranostic Trials: Future Indications.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.125.269486

Source records